Abstract:A B S T R A C TLung carcinogenesis is a complex process in an unregulated inflammatory environment.Curcumin has been extensively investigated as a multi-target anti-tumor and antiinflammation compound. In this paper, we demonstrate a novel inflammation-related mechanism for curcumin-induced inhibition of lung tumor growth. We found that neutrophil elastase, an important regulator of inflammatory processes, directly triggered tumor cell proliferation in human lung adenocarcinoma A549 cells, and curcumin could c… Show more
“…In tumor tissues of mice treated with curcumin, there was upregulation of α1-antitrypsin and decrease in the protein level of neutrophil elastase which play important roles in modulating lung tumor proliferation in inflammatory microenvironment. This study highlighted a new inflammation-related mechanism of curcumin against tumor proliferation and advocates the possible role of curcumin in the treatment of other inflammation-related diseases in lung such as emphysema [69]. Decrease in tumor growth and increase in survival contributed to T cell-mediated adaptive immune response was found in tumor-bearing mice treated with low-dose curcumin (50 mg/kg body weight) for ten days.…”
Lung cancer is a prominent cause of cancer-associated mortality worldwide. The main reason for high mortality due to lung cancer is attributable to the fact that the diagnosis is generally made when it has spread beyond a curable stage and cannot be treated surgically or with radiation therapy. Therefore, new approaches like dietary modifications could be extremely useful in reducing lung cancer incidences. Several fruits and vegetables offer a variety of bioactive compounds to afford protection against several diseases, including lung cancer. A number of research studies involving dietary agents provide strong evidence for their role in the prevention and treatment of lung cancer, and have identified their molecular mechanisms of action and potential targets. In this review article, we summarize data from in-vitro and in-vivo studies and where available, in clinical trials, on the effects of some of the most promising dietary agents against lung cancer.
“…In tumor tissues of mice treated with curcumin, there was upregulation of α1-antitrypsin and decrease in the protein level of neutrophil elastase which play important roles in modulating lung tumor proliferation in inflammatory microenvironment. This study highlighted a new inflammation-related mechanism of curcumin against tumor proliferation and advocates the possible role of curcumin in the treatment of other inflammation-related diseases in lung such as emphysema [69]. Decrease in tumor growth and increase in survival contributed to T cell-mediated adaptive immune response was found in tumor-bearing mice treated with low-dose curcumin (50 mg/kg body weight) for ten days.…”
Lung cancer is a prominent cause of cancer-associated mortality worldwide. The main reason for high mortality due to lung cancer is attributable to the fact that the diagnosis is generally made when it has spread beyond a curable stage and cannot be treated surgically or with radiation therapy. Therefore, new approaches like dietary modifications could be extremely useful in reducing lung cancer incidences. Several fruits and vegetables offer a variety of bioactive compounds to afford protection against several diseases, including lung cancer. A number of research studies involving dietary agents provide strong evidence for their role in the prevention and treatment of lung cancer, and have identified their molecular mechanisms of action and potential targets. In this review article, we summarize data from in-vitro and in-vivo studies and where available, in clinical trials, on the effects of some of the most promising dietary agents against lung cancer.
“…These properties have been heavily assessed for exploring its potential utilization in cancer treatment [28,29] . In addition, a few recent studies have reported the potential effect of curcumin in promoting white adipocyte "browning" [30,31] .…”
Section: Dietary Polyphenol and Dietary Polyphenol Interventionmentioning
Numerous natural products available over the counter are commonly consumed by healthy, sub-healthy or ill people for the treatment and prevention of various chronic diseases. Among them, a few dietary polyphenols, including the curry compound curcumin, have been attracting the most attention from biomedical researchers and drug developers. Unlike many so-called "good drug candidates", curcumin and several other dietary polyphenols do not have a single known therapeutic target or defined receptor. In addition, the bioavailability of these polyphenols is usually very low due to their poor absorption in the gut. These recently debated features have created enormous difficulties for drug developers. In this review, I do not discuss how to develop curcumin, other dietary polyphenols or their derivatives into pharmaceutical agents. Instead, I comment on how curcumin and dietary polyphenol research has enriched our knowledge of insulin signaling, including the presentation of my perspectives on how these studies will add to our understanding of the famous hepatic insulin function paradox.
“…Lung cancer accounts for about 18 % (1.4 million) of the death in 2008 [8] and estimated 28 % of the death in 2012 [9]. Recent studies highlighted that chronic inflammation is critical and dependent in the complex process of lung carcinogenesis [10]. Local infections (e.g., viral infections, pneumonia, or tuberculosis) and inflammation often occur in patients with lung cancer [11].…”
Inflammatory cells and mediators are essential components in tumor microenvironment and play decisive roles in the initiation, proliferation, survival, promotion, invasion, or metastasis of lung cancer. Clinical and epidemiologic studies suggested a strong association between inflammation and lung cancer and an influence of immune surveillances and tumor responses to chemotherapeutic drugs, although roles of inflammation in lung cancer remain unclear. The present review outlined roles of inflammation in lung cancer, with particular focus on inflammatory components, types, biomarkers, or principal mechanisms by which the inflammation contributes to the development of lung cancer. The cancer-associated inflammatory cells (CICs) should be furthermore defined and include cancer-specific and interacted cells with inflammatory or inflammation-like characteristics, e.g., innate or adaptive immune cells and cancer tissue cells. We also discuss targeting potentials of inflammation in the prevention and treatment of lung cancer. The diversity of cancer-related inflammatory microenvironment is instrumental to design novel therapeutic approaches for lung cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.